Literature DB >> 31787335

Surface engineering of nanomaterials with phospholipid-polyethylene glycol-derived functional conjugates for molecular imaging and targeted therapy.

Dinglin Zhang1, Jianxiang Zhang2.   

Abstract

In recent years, phospholipid-polyethylene glycol-derived functional conjugates have been widely employed to decorate different nanomaterials, due to their excellent biocompatibility, long blood circulation characteristics, and specific targeting capability. Numerous in vivo studies have demonstrated that nanomedicines peripherally engineered with phospholipid-polyethylene glycol-derived functional conjugates show significantly increased selective and efficient internalization by target cells/tissues. Targeting moieties including small-molecule ligands, peptides, proteins, and antibodies are generally conjugated onto PEGylated phospholipids to decorate liposomes, micelles, hybrid nanoparticles, nanocomplexes, and nanoemulsions for targeted delivery of diagnostic and therapeutic agents to diseased sites. In this review, the synthesis methods of phospholipid-polyethylene glycol-derived functional conjugates, biophysicochemical properties of nanomedicines decorated with these conjugates, factors dominating their targeting efficiency, as well as their applications for in vivo molecular imaging and targeted therapy were summarized and discussed.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Molecular imaging; Nanodiagnostics; Nanotherapies; Phospholipid-polyethylene glycol; Targeted therapy; Targeting ligands

Mesh:

Substances:

Year:  2019        PMID: 31787335     DOI: 10.1016/j.biomaterials.2019.119646

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  8 in total

1.  Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment.

Authors:  Xiao Liang; Yudi Wang; Hui Shi; Mengmeng Dong; Haobo Han; Quanshun Li
Journal:  Int J Nanomedicine       Date:  2021-03-30

2.  Conjugation of Native-Like HIV-1 Envelope Trimers onto Liposomes Using EDC/Sulfo-NHS Chemistry: Requirements and Limitations.

Authors:  Ehsan Suleiman; Julia Mayer; Elisabeth Lehner; Bianca Kohlhauser; Alexandra Katholnig; Mirjam Batzoni; Dominik Damm; Vladimir Temchura; Andreas Wagner; Klaus Überla; Karola Vorauer-Uhl
Journal:  Pharmaceutics       Date:  2020-10-16       Impact factor: 6.525

Review 3.  Nanomedicine-enabled chemotherapy-based synergetic cancer treatments.

Authors:  Wencheng Wu; Yinying Pu; Jianlin Shi
Journal:  J Nanobiotechnology       Date:  2022-01-04       Impact factor: 10.435

4.  Folic acid-modified ROS-responsive nanoparticles encapsulating luteolin for targeted breast cancer treatment.

Authors:  Yu Wang; Qianmei Wang; Wei Feng; Qian Yuan; Xiaowei Qi; Sheng Chen; Pu Yao; Qing Dai; Peiyuan Xia; Dinglin Zhang; Fengjun Sun
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

5.  Early diagnosis of breast cancer lung metastasis by nanoprobe-based luminescence imaging of the pre-metastatic niche.

Authors:  Hanwen Zheng; Chunsen Yuan; Jiajun Cai; Wendan Pu; Peng Wu; Chenwen Li; Gang Li; Yang Zhang; Jianxiang Zhang; Jiawei Guo; Dingde Huang
Journal:  J Nanobiotechnology       Date:  2022-03-15       Impact factor: 10.435

6.  Peptide-Functionalized Nanoemulsions as a Promising Tool for Isolation and Ex Vivo Culture of Circulating Tumor Cells.

Authors:  Nuria Carmona-Ule; Noga Gal; Carmen Abuín Redondo; María De La Fuente Freire; Rafael López López; Ana Belén Dávila-Ibáñez
Journal:  Bioengineering (Basel)       Date:  2022-08-10

7.  Liposomes Loaded with the Proteasome Inhibitor Z-Leucinyl-Leucinyl-Norleucinal are Effective in Inducing Apoptosis in Colorectal Cancer Cell Lines.

Authors:  Katia Cortese; Silvia Marconi; Cinzia Aiello; Maria Cristina Gagliani; Serena Pilato; Romina Zappacosta; Antonella Fontana; Patrizio Castagnola
Journal:  Membranes (Basel)       Date:  2020-05-03

Review 8.  Bioresponsive drug delivery systems for the treatment of inflammatory diseases.

Authors:  Yin Dou; Chenwen Li; Lanlan Li; Jiawei Guo; Jianxiang Zhang
Journal:  J Control Release       Date:  2020-09-08       Impact factor: 9.776

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.